Overexpression of DCF1 Inhibits Glioma through Destruction of Mitochondria and Activation of Apoptosis Pathway by Xie, Yuqiong et al.
Missouri University of Science and Technology 
Scholars' Mine 
Electrical and Computer Engineering Faculty 
Research & Creative Works Electrical and Computer Engineering 
01 Jan 2014 
Overexpression of DCF1 Inhibits Glioma through Destruction of 




Missouri University of Science and Technology, qyhb9@mst.edu 
Follow this and additional works at: https://scholarsmine.mst.edu/ele_comeng_facwork 
 Part of the Electrical and Computer Engineering Commons 
Recommended Citation 
Y. Xie et al., "Overexpression of DCF1 Inhibits Glioma through Destruction of Mitochondria and Activation 
of Apoptosis Pathway," Scientific Reports, vol. 4, Nature Research, Jan 2014. 
The definitive version is available at https://doi.org/10.1038/srep03702 
This work is licensed under a Creative Commons Attribution 4.0 License. 
This Article - Journal is brought to you for free and open access by Scholars' Mine. It has been accepted for 
inclusion in Electrical and Computer Engineering Faculty Research & Creative Works by an authorized administrator 
of Scholars' Mine. This work is protected by U. S. Copyright Law. Unauthorized use including reproduction for 
redistribution requires the permission of the copyright holder. For more information, please contact 
scholarsmine@mst.edu. 
Overexpression of DCF1 inhibits glioma
through destruction of mitochondria and
activation of apoptosis pathway
Yuqiong Xie1,2*, Qiang Li1,2*, Qingbo Yang1, Mei Yang1,2, Zhifeng Zhang1, Liucun Zhu2, Huang Yan1,
Ruili Feng1, Shiqing Zhang1,2, Chen Huang1, Zengrong Liu2 & Tieqiao Wen1,2
1Laboratory of Molecular Neural Biology, School of Life Sciences, Shanghai University, Shanghai 200444, China, 2Institute of
Systems Biology, Shanghai University, Shanghai 200444, China.
Gliomas are the most common brain tumors affecting the central nervous system and are associated with a
highmortality rate. DCF1 is a membrane protein that was previously found to play a role in neural stem cell
differentiation. In the present study, we found that overexpression of dcf1 significantly inhibited cell
proliferation, migration, and invasion and dramatically promoted apoptosis in the glioblastoma U251 cell
line. DCF1 deletion mutations in the functional region showed that the complete structure of DCF1 was
necessary for apoptosis. Furthermore, significantly lower tumorigenicity was observed in athymic nude
mice by transplanting U251 cells overexpressing dcf1. To decode the apoptosis induced by dcf1,
mitochondrial structure andmembrane potential in glioma cells were investigated and the results indicated
obvious mitochondrial swelling, destruction of cristae, and a significant decline in membrane potential.
Mechanismly, caspase-3 signaling was activated. Finally, endogenous dcf1 silence in U251 cells was
investigated. Results showed a highlymethylation at21339 and21322 position at dcf1 promoter sequence,
revealing the causal relationship between dcf1 gene and tumorigencicity. The present study identified a
previously unknown cancer apoptosis mechanism involving dcf1 overexpression and provided a novel
approach to potentially treat glioma patients.
G
lioblastomas (GBMs) are the most aggressive brain tumors in humans and have the worst prognoses,
with a median survival time of approximately 14 months and are almost invariably fatal1. Due to the
resistance of tumor cells to conventional therapies, it is very difficult to treat GBMs2–4; however, the
identification of genes or proteins that effectively inhibit tumor growth is expected to break through this bottle-
neck5. Our previous study revealed that dendritic cell factor (dcf1), also known as tmem59, was involved in
differentiation of neural stem cells (NSCs)6, since dcf1 silencing tends to differentiate NSCs into astrocytes7,8. We
further found that GFAP, a marker of astrocytes, was significantly upregulated both in gene and protein arrays
using dcf1 knockout mice, suggesting that theremay be a lower expression level of dcf1 in glioma cells. Gene array
analysis also showed that dcf1 expression in grade I and II gliomas was higher than that in grade III and IV (Sup
.1a), and dcf1 expression was decreased in the U251 glioma cell line compared to normal astrocyte cells (Sup .1b).
At the same time, we detected dcf1 expression in normal mouse brain tissue and transplanted gliomas, with
similar results (Sup .1c–e). In view of these assumptions, we transfected dcf1 into the U251 glioma cell line and
identified an obvious tumor suppression not only in the cells but also in vivo.
To study dcf1 membrane localization, we first performed immunofluorescence analysis using HeLa cells
overexpressing dcf1, and found that DCF1 was distributed outside the nucleus (Sup. 2a). Next, we constructed
a dcf1 vector using the pEGFP-N2 vector for transfection of U251 glioma cells, in which endogenous dcf1
expression was undetectable. The distribution of DCF1 in mitochondria was shown using the mitochondria-
specific dyeMitoTrackerHRedCMXRos (Fig. 1a). A closer examination revealedmitochondrial fragmentation or
fission9 upon ectopic DCF1 expression (Fig. 1b). Interestingly, all DCF1-expressing mitochondria were ruptured
(Fig. 1b1, b2), whereas those not expressing DCF1 remained normal (Fig. 1b4). The same was true even in the
same cell, non-expression of DCF1 retained normal mitochondrial structure (Fig. 1b3; white arrow on the left),
whereasDCF1 expression led to fragmentation of themitochondrial structure (Fig. 1b3; white arrow on the right),
suggesting a crucial step toward triggering cell apoptosis10,11.
To define the structural changes of mitochondria that are due to dcf1 expression, we observed mitochondria
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destruction were detected in cells overexpressing DCF1 (Fig. 1c;
black arrow)13. Changes in mitochondrial morphology was further
investigated using atomic force microscopy (AFM), which showed
that the mitochondria swelled to 1700 nm in cells overexpressing
DCF1, which was more than twice that of controls (Fig. 1d), suggest-
ing the role of DCF1 in mitochondrial destruction. At the same time,
we discovered many hollow spaces in the outer membrane of the
mitochondria (indicated by white arrow), suggesting the opening of
mitochondrial permeability transition pores14.
Following our observations ofmitochondrial damage inU251 cells
caused by DCF1 overexpression, we next examined the effects of
DCF1 on cell viability including proliferation, migration, and inva-
sion. The cell proliferation rate was evaluated using a CCK-8 Cell
Counting Kit at 24, 36, 48, 60, and 72 h post-transfection15. In com-
parison to control groups, exogenous DCF1 significantly inhibited
growth of U251 cells at 24–72 h post-transfection (Fig. 2a). The same
result was shown in the glioma cell line U87-MG, although not as
extensive as in U251 cells (Fig. 2b). However, there was no inhibition
of DCF1 in other tumor cell lines, including MCF-7, H1299, K-562,
and HEK293T, demonstrating specific inhibition of DCF1 in glioma
cells. Considering the important characteristics of tumor cells, we
next investigated the effects of DCF1 on cell migration and inva-
sion16–18. When dcf1 was expressed in U251 cells, both cell migration
and invasion were significantly decreased compared with control
cells (Fig. 2c and 2e; Sup. 2b)19.
To examine the functional region in DCF1, we examined the
entire protein sequence using the PSORTNakai Server (psort.hgc.jp)
and determined the existence of an N-terminal signal sequence,
mitochondrial targeting sequential motif, a transmembrane region,
and a cytoplasmic tail. Next, we designed and constructed 4 deletion
mutants corresponding to these regions (Fig. 2d) and investigated the
mitochondrial membrane potential20 following transfection with
full-length wild-type dcf1 and the 4 mutants in U251 cells. CCCP,
a proton ionophore that disrupts membrane potential, was used as a
positive control and the results showed conclusively that only the
complete structure of DCF1 reduced membrane potential21, whereas
the other mutants did not have the same efficiency (Fig. 2f). Similar
results were shown in U87-MG cells (Sup 3a). Therefore, we inves-
tigated whether energy generation changed in such a state. As
expected, ATP concentration in cells transfected with full-length
dcf1 was significantly reduced to approximately 30% of that in other
mutants and controls (Fig. 2g), indicating the requirement of DCF1
integrity for biological function.
Next, apoptosis of glioma cells was investigated using fluorescence
activated cell sorting. After dcf1 transfection for 48 h, 75.1% and
13.4% of cells were in the early and late stages of apoptosis, respect-
ively, compared with control cells (Fig. 3a). The TUNEL assay was
also used to detect apoptosis in U251 cells and the results confirmed
the occurrence of late apoptosis (Fig. 3b).Apoptosis was further iden-
tified using TEM and the results showed DCF1 overexpression
initiated a series of apoptotic phenomenon, such as cytoplasmic
shrinkage, nuclear fragmentation, autophagosome formation and
clusters of vacuoles in the cytoplasm (Fig. 3c).
To examine the apoptotic signal mechanism induced by DCF1,
we evaluated expression changes in the apoptosis-related proteins
Bcl-2 and Bax22. Western blotting showed that DCF1 overexpression
Figure 1 | dcf1 overexpression caused mitochondrial fission in U251 glioma cell lines. (a). Co-localization of dcf1 (green) and mitochondria (red) in
U251 cells transfected with pEGFP-N2-DCF1. Scale bars, 10000 nm. (b). dcf1 expression leaded to mitochondrial fisson, showing a precursor of cell
apoptosis. The mitochondria fissioned in the presence of dcf1 (b1, b2), but remained normal in the cell without transfection of dcf1 (b4). (c). TEM image
of swelled mitochondria and almost disappeared cristae(black arrow) in U251 cell overexpressed with DCF1. Scale bars,0.5 mm. (d).AFM image of out
membrane appearance change of swelled mitochondrial in U251 cell overexpressed with DCF1. Scale bars, 10000 nm.
www.nature.com/scientificreports
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up-regulated pro-apoptotic protein Bax expression, whereas it
down-regulated anti-apoptotic protein Bcl-2. Next, we investigated
whether DCF1 mediated the activation of caspase-3, an apoptosis-
related cysteine peptidase. Western blotting revealed that Pro-cas-
pase-3 was cleaved into two activated subunits, suggesting that DCF1
induced glioma cell apoptosis via the Bcl-2 protein family and finally
activated the caspase-3 signaling pathway (Fig. 4a). To elucidate the
apoptotic mechanisms induced by DCF1 at a systemic level, we
proposed a signaling network based on the existing literature and
our experiments (Fig. 4b), including known mitochondrial mem-
brane permeability transition pore proteins HTRA2, BIRC2,
DIABLO, and CYCS, as well as the apoptosis complex protein
APAF123,24. Through activation of BAX, inhibition of BCL-2, and
damage to mitochondria, DCF1 eventually leads to apoptosis by
activating caspase-3 in an intrinsic apoptosis pathway.
Assuming that tumorigenesis was caused by the downregulation
of dcf1, we subcutaneously injected U251 and U251-dcf1 cells into
the right flank of nude mice to investigate its tumorigenicity25. After
transplantation of U251 cells, tumors were visible at the transplant
site with 75% tumorigenicity, whereas nude mice transplanted with
U251-dcf1 cells showed tumorigenicity of only 25% (Fig. 4c). More
importantly, the difference in tumor size was significant, as the aver-
age tumor volume was . 10-fold greater in U251 cells than that in
U251-dcf1 cells (Fig. 4d). In addition, tumors in the control groups
(U251 cells) had rich vessel distribution, with increased proliferation
ability compared with that in the experimental group (U251-dcf1
cells), in which the vessels appeared dark (Fig. 4d). Incidentally,
when we evaluated GFAP expression in primary glioma cells isolated
from the tumors, the U251-dcf1 group showed less glioma content
than the controls (Sup .3b). An in vivo assay clearly showed that dcf1
indeed contributed to glioma tumorigenicity and could serve as a
potential therapeutic target for glioma treatment.
Thanks of a lower expression of dcf1 in the U251 glioma cell,
we finally argued the causal relationship between dcf1 and tumor-
igenicity. We found by Bisulfite-modified genomic DNA analysis
that there are 3 CpG sites (21339, 21322, 21299) from 21350 to
Figure 2 | DCF1 suppressed glioma cell proliferation, migration and invasion via declining mitochondrial membrane potential and decreaseing ATP
synthesis. (a), (b),The cell proliferation in U251 andU87-MGwere significantly inhibited in the expression of DCF1 by CCK8 assay. (c),Themigration of
U251 was also significantly decreased with DCF1 expression. (d). The schematic diagram of DCF1 deletion in 4 different sites. (e). Full-length sequence of
DCF1 leaded to a decrease of cell invasion in U251, but mutants had no effects on it. (f). Full-length sequence of DCF1 leaded to a decrease of
mitochondrial membrane potential, but different mutant in DCF1 remained normal state. Scale bars, 200 mm. (g). ATP concentration in cells was
significantly reduced compared with mutants in expression of DCF1 suggesting the necessity of a complete sequence of DCF1 in executing its function.
(n 5 3 per group,*P , 0.05,**P , 0.01,***P , 0.001). Error bars, s.d.
www.nature.com/scientificreports
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21200 with a complete methylation in dcf1 promoter in U251 cells
(Fig. 5 A). To investigate the release from methylation –mediated
repression, 5-Azacytidine, an inhibitor of DNA methyltransferaes
was used. Results show that expression of dcf1 at both protein and
mRNA levels is in a concentration-dependent manner (Fig. 5 B and
Fig. 5 C). Correspondingly, methylation mutation at 21339 and
21322 was demonstrated a significant upregulation of dcf1 gene
(Fig. 5 D). Further, to assess the effect of dcf1 demethylation on
the tumor proliferation, CCK-8 assay was used to detect the viability
in cultured U251 glioma cells. The results showed that compared
with controls, cells treated with 5-Azacytidine were significantly
reduced in cell proliferation, powerfully indicating inhibition of
dcf1 to tumorigenicity (Fig. 5 E).
Gliomas are the most lethal brain cancers. Despite great efforts to
improve treatment, the survival time of patients remains 14–16
months after diagnosis26. It is therefore particularly important to find
an effective treatment for gliomas. Recently, Dyn2 is as an effector to
mediates glioma tumor growth and invasion26. Silence of Dyn2
inhibited PDGFR alpha-stimulated phosphorylation of Akt and
tumor growth and invasion. HES6, a transcription cofactor, was
highly expressed in glioma samples. HES6 silencing showed a reduc-
tion of cancer cell proliferation and migration27.
Admittedly, it has been found that many genes are up- or
down-regulated in tumorigenesis. Unfortunately, it has not so far
found a truly effective treatment of gliomas. In this study, we find
that the overexpression of DCF1 significantly inhibits glioma cell
Figure 3 | DCF1 caused U251 cell apoptosis. (a). After transfection of dcf1 for 48 h, the early apoptosis accounting for about 75% and the late apoptosis
accounting for about 13% were analyzed by Annexin V-APC/7-AAD flow cytometry detection. (b). Late cell apoptosis (red) was analyzed by TUNEL
methods after transfection of dcf1 for 72 h. Scale bars,10000 nm (c). TEM revealed the occurrence of apoptosis, such as nucleus fragmentation(N),
intracellular vacuolization(V), and autophagosome formation(A). Scale bars, 1 mm.
www.nature.com/scientificreports
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proliferation, survivor and ultimately leads to apoptosis, pushing a
step forward in understanding the mechanism of tumorigenesis28.
To better understand dcf1 functional mechanisms, we proposed
a model based on our experiments and the literature (Sup Fig. 4).
In normal mitochondria with cristae integrity, cytochrome c is
distributed between the outer and inner mitochondrial mem-
branes29, AIF locates in the inner membrane and Bax partly locates
in the cytoplasm22,30. Mitochondrial membrane potential and ATP
synthesis maintain normal, cellular physiological activity and pro-
caspase-3 remains in a non-activated state31. When DCF1 is over-
expressed, it is embedded in the inner mitochondrial membrane,
leading to destruction of the membrane structure, mitochondrial
swelling, decreased mitochondrial membrane potential, and inhib-
ited ATP synthesis. This extraneous interference disturbed mito-
chondrial homeostasis32, resulted in activating of BH-3 only
protein10. Then activated BH-3 only protein combined anti-apop-
totic protein Bcl-2, and induced changes in Bcl-2 formation11,33.
Bax then released from Bcl-2, transferred into the outer mitochon-
drial membrane34,35, and combined with Bak in a dimeric complex
comprising the mitochondrial permeability transition pore36, which
altered mitochondrial outer membrane permeability and leaded to
partial rupturing of the outer membrane, resulting in mitochon-
drial swelling in a spherical shape37. Cytochrome c and AIF were
released from the mitochondrial membrane interval29,38, and it
further participated in the formation of apoptosomes along with
procaspase-9, dATP, and APAF-1, which actives downstream cas-
pase enzymes39. Procaspase-3 then becomes active caspase-340. On
the other hand, after release from the mitochondria, AIF enters the
nucleus and induces nuclear shrinking and DNA fragmentation.
Methods
All experiments were performed in accordance with guidelines and
regulations,Shanghai University Ethics Committee approved the experiments.
Plasmid construction. Human dcf1 cDNA was amplified by PCR with Pyrococcus
furiosusDNApolymerase, then subcloned into the EcoRI and BamHI restriction sites
in the pEGFP-N2 plasmid. For construction of the 4 mutants, the following primers
were used: pEGFP-N2-DCF1 (sense, 59-CGGAATTCATGGCGGCGCCGAA-
GGGGAG-39; antisense, 59-CGGGATCCGTAAAATTTCAGAATGAGCA-39); pN-





39); and pTrans-DCF1 (sense-1, 59-CGGAATTCATGGCGGCGCCGAAGGGGAG-
39; antisense-2, 59-GCTCTAGAAGTTGTAGTTAAAATCCA-39; sense-2, 59-
GCTCTAGAACAGCTGTGGAGCAGTAT-39; antisense-2, 59-CGGGATCCG-
TAAAATTTCAGAATGAGCA-39); pC-tail-DCF1 (sense, 59-CGGAATTCATGG-
CGGCGCCGAAGGGGAG-39; antisense, 59-CGCGGATCCAGCAACAGTTGC-
ACAACA-39).
Cell cultures. The U251, U87, and HEK293T cell lines were cultured in high-glucose
DMEM supplemented with 10% fetal bovine serum (FBS), 1 mM glutamine, 100 U/
ml penicillin, and 100 mg/ml streptomycin at 37uC in a humidified atmosphere of 5%
CO2. MCF-7, K-562, and H1299 cell lines were cultured in Roswell Park Memorial
Institute 1640 medium supplemented with 10% FBS, 1 mM glutamine, 100 U/ml
penicillin, and 100 mg/ml streptomycin, at 37uC in a humidified atmosphere of 5%
CO2.
Cell transfection.U251 cells were plated in 24-well plates at a density of 13 105 cells/
well and cultured at 37uC in an atmosphere of 5% CO2 overnight for transfection. A
total of l mg pEGFP-N2-DCF1 DNA per well was transfected into U251 cells using
Lipofectamine 2000 according to the manufacturer’s protocol.
MitoTracker Red staining.Mitochondrialmorphologywas detected byMitoTracker
Red staining. After transfection with pEGFP-N2-DCF1 for 48 h, the culture medium
was removed and the cells were stained with pre-warmed 151500 10% FBS–DMEM
diluted MitoTrackerH Red CMXRos dye (Invitrogen) at 37uC for 30 min in a
humidified atmosphere of 5% CO2. Then, the loading solution was replaced with
fresh pre-warmed 10% FBS–DMEM. After staining, the cells were observed
immediately by confocal laser microscopy.
TEM observation. After transfection for 48 h, U251 cells were harvested using a cell
scraper and then washed 3 times with PBS. After centrifugation, cells were fixed with
Figure 4 | Analyze apoptosis-related proteins and tumorigenicity in vivo. (a). Western blotting showed that anti-apoptotic protein (Bcl-2) was
downregulated, pro-apoptotic protein (Bax) was upregulated, and caspase-3 was activated. (the blots were cropped, and the full-length blots were
included in the supplementary information) (b). Prediction of the apoptosis pathway mediated by DCF1. (c), (d). Injection of U251 cells expressed dcf1
into nude mice showed a low tumorigenicity rate and a small tumor volume compared with control groups.
www.nature.com/scientificreports
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1% glutaraldehyde at 4uC overnight, and then fixed with 1% osmium tetroxide at 4uC
for 3 h. After dehydration and resin embedding, U251 cells were sectioned to a 70-nm
thickness, stainedwith uranyl acetate and lead citrate, and the ultrathin sectioned cells
were observed using TEM.
Mitochondrial AFM observation. After transfection with plasmid pEGFP-N2 or
recombinant plasmid pEGFP-N2-DCF1, mitochondria of U251 cells were isolated
using the Mitochondrial Protein Extraction Kit (KeyGen Biotech) using the
manufacturer’s protocol. Morphological analysis of U251mitochondria was achieved
using an ex situ Agilent 5500 AFM system (Santa Clara, CA), with a scan rate in a
tapping mode of 0.5–1 Hz and resonant frequency in the range 160–260 kHz.
Cell proliferation.The effect of dcf1 on cell proliferationwas assessed using the CCK-
8Cell Counting Kit. In brief, after seeding cells in 96-well plates for 24 h, the cells were
transfected with plasmid pEGFP-N2 or recombinant plasmid pEGFP-N2-DCF1.
CCK-8 solution was added to each well at 12-h intervals. After the cells were
incubated with CCK-8 solution for 30 min, the absorbance at 450 nm was measured
using a microplate reader (Bio-Rad).The cell viability was characterized by optical
absorption and each experiment was performed in triplicate.
Cell invasion.The effect of dcf1 on cell proliferationwas assessed using the BioCoatTM
MatrigelTM Invasion Chamber (BD354480). After transfection of the 4 mutant cell
lines with pEGFP-N2 and pEGFP-N2-DCF1 for 48 h, the cells were harvested and
adjusted to a density to 53 104/ml. After incubation in the invasion chamber for 22 h
in a humidified atmosphere of 5% CO2, non-invaded cells were scrubbed with a
cotton swab, and transfected cells were stained with crystal violetand observed using a
Nikon Ti-S fluorescence microscopeat a magnification of 1003.
JC-1 assay. The mitochondrial membrane potential was evaluated by using the JC-1
Mitochondrial Membrane Potential Detection Kit (Beyotime). In brief, before
staining, 151000 diluted CCCP was added as a positive control for 30 min in a
humidified atmosphere of 5% CO2. After transfection for 48 h, cells were incubated
with 13 JC-1 staining solution in 24-well plates for 20 min at 37uC, and rinsed twice
with 13 staining buffer. Finally, cells cultured in 10% FBS/DMEM were detected
using a Nikon Ti-S fluorescence microscope.
Cellular ATP assay. ATP concentration was detected using the ATP Assay Kit
(Beyotime). In brief, cells, including the 4 mutant strains, were cultured in 6-well
plates after transfection with pEGFP-N2 or pEGFP-N2-DCF1 for 48 h, lysed, and
then centrifuged at 12,000 rpm for 10 min to isolate total protein. Next, 100 ml of
supernatant was added to 100 ml of ATP detection solution and standard samples
were generated. Luminescence was immediately detected using a plate reader
(PerkinElmer). Protein concentration was measured using the Bradford assay.
Flow cytometry. After transfection with pEGFP-N2 or pEGFP-N2-DCF1 for 48 h,
U251 cells were digested with trypsin (0.25% in D-Hanks solution without EDTA)
and harvested (13 106 cells) in 10% FBS–DMEM. Next, cells were washed twice with
2%-BSA–PBS, then resuspended in 500 ml of binding buffer, combined with 5 ml
annexin V-APC, and gently mixed. Next, 5 ml of 7-AAD was added according to the
protocol of the Annexin V-APC/7-AAD Apoptosis Detection Kit (KeyGen Biotech).
Samples were cultured at room temperature for 15 min before flow cytometry
(Beckman).
TUNEL assay. U251 cells were rinsed with PBS, fixed in 4% paraformaldehyde for
30 min at room temperature, permeabilized with 1% Triton X-100 for 5 min, and
blocked with 3% H202 at room temperature for 10 min. The samples were washed 3
times with PBS, 50 ml TdT enzyme reaction buffer was added to the slide, and
incubated at 37uC for 1 h as described in the protocol of the TUNEL Apoptosis
DetectionKit (KeyGENBiotech). After removal of the reaction buffer, the sample was
incubated with 50 ml DAPI for 5 min. Fluorescence at 543 nmwas detected using the
Zeiss LSM 710 confocal microscope.
Immunofluorescence. U251 cells were rinsed with PBS, fixed in 4%
paraformaldehyde for 10 min at room temperature, and permeabilized with 0.1%
Triton X-100 for 10 min. The cells were blocked with 2% BSA–PBS at room
temperature for 60 min, and incubated with primary antibodies at 4uC overnight.
After washing 3 times with PBS, cells were incubated with secondary antibodies for
50 min at 37uC, and fluorescence at 488 nm (FITC) and 543 nm (TRITC) were
detected using the Nikon Ti-S fluorescence microscope.
Western blotting. At 48 h after transfection, the cells were washed twice with ice-
cold PBS and protein was extracted according to the manufacturer’s protocol
Figure 5 | Effects of dcf1 methylation in promoter on the dcf1 expression and cell proliferation. (A). a Highly methylated at 21339, 21322, 21299 of
dcf1 promoter from 21350 to the ATG start codon. (B). Western blot analysis of dcf1 when treated with 5-Azacytidine(2.5 mM, 50 mM), normalize
with b-actin. (the blots were cropped, and the full-length blots were included in the supplementary information) (C). dcf1mRNA expression signifcantly
up regulated in treatment of 2.5 mM, 50 mM 5-Azacytidine respectively. (D). dcf1 mutation in 21339 and 21322 leads to dcf1 up-regulation.
(E). demethylation of dcf1 supresses cell proliferation, supporting that dcf1 expression inhibits tumorigenicity. The values represent the mean 6 SE of
three or more experiments. * p , 0.05, ** p , 0.01.
www.nature.com/scientificreports
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(Beyotime). Protein concentrations were detected using the BCA Protein Assay Kit
(Beyotime). The total protein (30 mg) was separated by 12% SDS-PAGE and
electroblotted onto nitrocellulosemembranes, which were blockedwith 5%BSA–PBS
for 1 h at room temperature, and then incubated with b-actin antibody (151000;
Santa Cruz), DCF1 (153000), Bcl-2 (152000, CST), Bax (152000, CST), and
procaspase-3 (152000, CST) overnight at 4uC. Next infrared dye 800-conjugated
affinity-purified goat anti-rat IgG (Zemed, USA) and infrared dye 700-labeled goat
anti-rabbit IgG (Zemed, USA) secondary antibodies were added and incubated for
1 h at room temperature. Immunoblotting bands were detected and quantified using
the LI-COR Odyssey infrared imaging system (simultaneous two-color targeted
analysis) and software (LI-COR).
Cellular tumorigenicity in nude mice. U251 cells transfected with control plasmids
or pEGFP-N2-DCF1 for 48 h, harvested by trypsin digestion, then 107 cells were
injected subcutaneously into the right flank of the nude mice (4 mice/treatment
group).
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